悄悄主宰美国人生活的财富500强企业

美源伯根（AmerisourceBergen）

    在你购买的药品背后，是一个建立在药品供应、定价和补贴之上的完整产业，这也正是美源培根的业务所在。2001年美源健康公司（Amerisource Health Corporation）和伯根布鲁斯威格公司（Bergen Brunswing Corporation）合并，形成美源伯根。如今，这一整合后的公司掌握着全美20%的药品分销网络，旗下全职员工多达13,400人。

    为了应对医疗改革（届时政府将成为药品采购方面更强大的对手），制药行业掀起了合并潮，企业纷纷壮大自己的力量。为此，美源伯根与快捷药方（Express Scripts）签署了一份为期3年的合同。快捷药方不久前刚完成对美可保健公司（Medco Health）的收购，双方都是药品供应商和顾问公司。2013年，美源伯根与沃尔格林（Walgreen）和联合博姿（Alliance Boots）又签署了一项协议。这项协议能使三方联手的仿制药采购量超越行业内任何其他公司。

AmerisourceBergen

    Behind the drugs you buy is an entire industry built on supplying, pricing, and subsidizing those meds, which is where AmerisourceBergen lives. The megapharma company was formed in 2001, when Amerisource Health Corporation merged with Bergen Brunswig Corporation. Today, the resulting hybrid handles 20% of all of the pharmaceuticals sold and distributed throughout the United States, and employs 13,400 people full-time.

    The pharma industry has undergone consolidation, with companies forming even larger units to prepare for health care reform, when the government will become an even more powerful drug-purchasing competitor. So AmerisourceBergen signed a three-year contract with Express Scripts, which had just bought Medco Health. Both Express Scripts and Medco are pharma suppliers and consultants. In 2013, AmeriSourceBergen penned a deal with Walgreen (WAG, Fortune 500) and Alliance Boots. The deal could give the triad the purchasing power to buy more generics than any other purchaser in the industry.